SP²TX: Engineering the Future of Peptide Therapeutics
Unlocking the power of peptides through scalable synthesis and design-driven innovation. A Seoul National University spinoff combining cutting-edge science, automation, and translational biotech execution.
Patent-pending technology combining SPPS with resin-based flow chemistry
Meeting Critical Market Demand
Supply Shortages
Peptide drugs like Eli Lilly's Mounjaro face significant shortages due to unprecedented patient demand.
FDA Recognition
The US Food and Drug Administration has reported sporadic backorders of critical peptide therapeutics.
Market Opportunity
Current production methods cannot meet growing demand, creating an urgent need for innovative solutions.
FLOWSMART™️
for Rapid Turnaround
20x
Faster Synthesis
Accelerate drug trials with synthesis speeds 20 times quicker than existing methods
10x
Cost Reduction
Slash synthesis expenses by more than 10 times compared to traditional approaches
15x
Lower Entry Cost
Reduce initial investment requirements by 15 times, enabling broader access
Scale & Efficiency Advantages
Lab-Scale Synthesis
Precise small-batch production
Industrial Production
Seamless scaling to manufacturing
Consistent Quality
Uniform results across all scales
Combating the Obesity Epidemic
Appetite Control
Targeting molecular mechanisms that regulate hunger
Energy Optimization
Enhancing metabolic efficiency
Metabolism Enhancement
Improving the body's natural calorie-burning processes
Oral Delivery
Innovative formulations for convenient administration
Expanding Applications
Peptide Nucleic Acids
Our technology unlocks transformative solutions in genetic medicine, offering potential cures and treatments that are both innovative and effective.
High-Performance Cosmetics
We're crafting superior skincare products that blend scientific rigor with cosmetic artistry, creating formulations that rejuvenate and protect while setting new beauty standards.